Biovail's Orally Disintegrating Tramadol Clears FDA
This article was originally published in The Pink Sheet Daily
Executive Summary
The company is not deciding on a brand name for tramadol ODT until it establishes a strategic marketing partner. Biovail says it is in late-stage discussions with partners for tramadol ODT and extended-release tramadol, which is "approvable" at FDA.
You may also be interested in...
Biovail To Market Tramadol Under Ortho’s Ultram Brand
The partnership for tramadol extended-release and once-daily formulations will grant Biovail use of the Ultram trade name.
Biovail To Market Tramadol Under Ortho’s Ultram Brand
The partnership for tramadol extended-release and once-daily formulations will grant Biovail use of the Ultram trade name.
Biovail’s Tramadol ER Approved Without Additional Clinical Studies
The company expects the analgesic to launch early in 2006, but continues negotiations over a marketing partnership.